Clinical trials: Mpulse Control Disorders
Parkinson's Disease, Mpulse Control Disorders
Study of Clonidine Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease:
Noradrenergic system is involved in impulsivity in the general population and is altered in Parkinson's disease (PD) in the early stages of the disease.
- Trial name
- ID-CLO (NCT03552068)
- Testing
- Clonidine
- Where
- France
- Volunteers
- 38 people
- Sponsor
- Hospices Civils de Lyon